将2019年冠状病毒病检测政策与研究转变为纳入完整翻译流程。
Shifting Coronavirus Disease 2019 Testing Policy and Research to Include the Full Translation Pipeline.
作者信息
Catania Joseph A, Martin Jeffrey, Dolcini M Margaret, Orellana E Roberto, Henne Jeffrey
机构信息
Oregon State University Hallie E. Ford Center and Health Promotion and Health Behavior Program, College of Public Health and Human Sciences, Corvallis, Oregon, USA.
University of California San Francisco, Department of Epidemiology and Biostatistics, San Francisco, California, USA.
出版信息
Open Forum Infect Dis. 2021 Jan 5;8(2):ofaa649. doi: 10.1093/ofid/ofaa649. eCollection 2021 Feb.
Abstract
The current severe acute respiratory syndrome coronavirus 2 testing policy and practice limits testing as a prevention tool. Radical shifts are required to increase the scale of rapid testing strategies and improve dissemination and implementation of venue-based and self-testing approaches. Attention to the full translation pipeline is required to reach high-risk segments of the population.
摘要
当前的严重急性呼吸综合征冠状病毒2检测政策和做法将检测限制为一种预防工具。需要进行彻底转变，以扩大快速检测策略的规模，并改进基于场所的检测方法和自我检测方法的推广与实施。需要关注整个翻译流程，以覆盖高风险人群。
相似文献
1
Shifting Coronavirus Disease 2019 Testing Policy and Research to Include the Full Translation Pipeline.将2019年冠状病毒病检测政策与研究转变为纳入完整翻译流程。
Open Forum Infect Dis. 2021 Jan 5;8(2):ofaa649. doi: 10.1093/ofid/ofaa649. eCollection 2021 Feb.
2
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益（CoV-Surv 研究）：一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
3
SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.SPIKE-1：一项在社区环境中进行的随机 II/III 期试验，评估了使用卡莫司他通过阻断 SARS-CoV-2 刺突蛋白引发的膜融合来减少 COVID-19 临床进展的效果。
Trials. 2021 Aug 19;22(1):550. doi: 10.1186/s13063-021-05461-9.
4
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性（COVA 研究）：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
5
A Mobile Health Platform to Disseminate Validated Institutional Measurements During the COVID-19 Outbreak: Utilization-Focused Evaluation Study.在 COVID-19 疫情期间传播经过验证的机构测量值的移动医疗平台：基于利用的评估研究。
JMIR Public Health Surveill. 2020 Apr 14;6(2):e18668. doi: 10.2196/18668.
6
Severe Acute Respiratory Syndrome Coronavirus 2: Manifestations of Disease and Approaches to Treatment and Prevention in Humans.严重急性呼吸综合征冠状病毒 2：人类疾病的表现及治疗和预防方法。
Comp Med. 2021 Oct 1;71(5):342-358. doi: 10.30802/AALAS-CM-21-000011. Epub 2021 Sep 17.
7
Long, thin transmission chains of Severe Acute Respiratory Syndrome Coronavirus 2 may go undetected for several weeks at low to moderate reproduction numbers: Implications for containment and elimination strategy.严重急性呼吸综合征冠状病毒2的长而细的传播链在低至中等繁殖数情况下可能数周未被发现：对控制和消除策略的影响。
Infect Dis Model. 2021;6:474-489. doi: 10.1016/j.idm.2021.02.002. Epub 2021 Feb 23.
8
Assessment of the clinical and analytical performance of three Seegene Allplex SARS-CoV-2 assays within the VALCOR framework.在 VALCOR 框架内评估三款 Seegene Allplex SARS-CoV-2 检测试剂盒的临床和分析性能。
Microbiol Spectr. 2024 Feb 6;12(2):e0239723. doi: 10.1128/spectrum.02397-23. Epub 2024 Jan 8.
9
Biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the humoral immunoresponse: a systematic review of evidence to support global policy-level actions and research.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的生物学特性与体液免疫反应：支持全球政策层面行动和研究的证据的系统综述
Glob Health J. 2022 Mar;6(1):38-43. doi: 10.1016/j.glohj.2021.11.005. Epub 2021 Nov 19.
10
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染：综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
引用本文的文献
1
Balancing timeliness of reporting with increasing testing probability for epidemic data.平衡疫情数据报告的及时性与提高检测概率。
Infect Dis Model. 2022 Apr 6;7(2):106-116. doi: 10.1016/j.idm.2022.04.001. eCollection 2022 Jun.
本文引用的文献
1
Comparing the effects of HIV self-testing to standard HIV testing for key populations: a systematic review and meta-analysis.比较 HIV 自我检测与标准 HIV 检测对关键人群的影响：系统评价和荟萃分析。
BMC Med. 2020 Dec 3;18(1):381. doi: 10.1186/s12916-020-01835-z.
2
The Challenges of Expanding Rapid Tests to Curb COVID-19.扩大快速检测以遏制新冠疫情面临的挑战
JAMA. 2020 Nov 10;324(18):1813-1815. doi: 10.1001/jama.2020.21106.
3
Fast, cheap tests could enable safer reopening.快速、廉价的检测可以实现更安全的重新开放。
Science. 2020 Aug 7;369(6504):608-609. doi: 10.1126/science.369.6504.608.
4
Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States.评估 SARS-CoV-2 筛查策略，以允许美国大学校园安全重新开放。
JAMA Netw Open. 2020 Jul 1;3(7):e2016818. doi: 10.1001/jamanetworkopen.2020.16818.
5
Economic, Mental Health, HIV Prevention and HIV Treatment Impacts of COVID-19 and the COVID-19 Response on a Global Sample of Cisgender Gay Men and Other Men Who Have Sex with Men.全球范围内顺性别男同性恋者和其他男男性行为者中 COVID-19 及其应对措施对经济、心理健康、艾滋病毒预防和艾滋病毒治疗的影响。
AIDS Behav. 2021 Feb;25(2):311-321. doi: 10.1007/s10461-020-02969-0.
6
Rapid Uptake of Home-Based HIV Self-testing During Social Distancing for SARS-CoV2 Infection in Oregon.俄勒冈州在社交隔离期间，为应对 SARS-CoV2 感染，HIV 自我检测在家中快速普及。
AIDS Behav. 2021 Jan;25(1):167-170. doi: 10.1007/s10461-020-02959-2.
7
Covid-19 antibody tests: a briefing.新冠病毒-19抗体检测：简报
BMJ. 2020 Jun 24;369:m2284. doi: 10.1136/bmj.m2284.
8
Assessment of Sensitivity and Specificity of Patient-Collected Lower Nasal Specimens for Severe Acute Respiratory Syndrome Coronavirus 2Testing.患者采集的下鼻拭子用于严重急性呼吸综合征冠状病毒 2 检测的敏感性和特异性评估。
JAMA Netw Open. 2020 Jun 1;3(6):e2012005. doi: 10.1001/jamanetworkopen.2020.12005.
9
Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing.患者或医护人员采集的用于新型冠状病毒检测的拭子。
N Engl J Med. 2020 Jul 30;383(5):494-496. doi: 10.1056/NEJMc2016321. Epub 2020 Jun 3.
10
Remdesivir for the Treatment of Covid-19 - Final Report.瑞德西韦治疗 COVID-19 的疗效 - 最终报告。
N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.
Zotero 插件